Dr. Ling Wong is a trained scientist turned investor with MIT and Harvard backgrounds who operates as a solo General Partner at Highbury Group while simultaneously serving as General Partner of Sea Lane Ventures and Senior Advisor to Lightspeed Venture Partners. She focuses on healthcare companies that use science and technology to improve healthcare access and health equity, particularly backing data-driven and AI-enabled health platforms that push boundaries rather than incremental improvements.

• A distinct focus on startups that address social determinants of health and aim to eliminate inequalities in the system. This is evident in the repeated support for Soda Health, specifically regarding their work to ensure supplemental benefits actually reach the people who need them so no money is left on the table.
• Strong interest in the infrastructure layer of virtual care and telehealth. Rather than just patient-facing apps, there is excitement around platforms like Wheel Health that power virtual-first care models and help scale operations globally through strategic moves like acquiring GoodRx Care.
• Deep engagement with complex biotechnology and therapeutics, particularly in regenerative medicine and immunology. This includes backing Satellite Bio for their tissue therapeutics approach to liver disease and Seismic Tx for applying machine learning to drug development.
• Support for technologies specifically designing better care models for seniors and vulnerable populations. This is highlighted by the board appointment at Curve Health and the promotion of their mission to deliver best-in-class technology to older adults.
• Appreciation for founders who are fixing fragmented market sectors to improve system efficiency. The tweets often praise companies like Soda Health or Wheel for connecting disconnected parts of the healthcare market to ensure smoother delivery of care and benefits.